Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Jardiance Gets Heart Failure Nod, But How Long Will Its Reign Last?
Feb 25 2022
•
By
Alaric DeArment
Eli Lilly and Boehringer Ingelheim's Jardiance received FDA approval for heart failure with preserved ejection fraction • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip